2 reports

The ASEAN and North Asian Point of Care/Rapid Diagnostics market size is expected to grow from an estimated USD 2.0 billion in 2021 to USD 3.9 billion by 2026, at a CAGR of 13.0%. The growing demand for accurate and early diagnostic methodologies, modernization and expansion of healthcare infrastructure and significant disease prevalence are...

  • Diagnostics
  • Asia
  • Health Expenditure
  • Gross Domestic Expenditure On R&D

The global plant-based vaccines market is expected to reach US$ 2,672.05 million by 2028 from US$ 1,143.72 million in 2021, growing at a CAGR of 12.9 % from 2021 to 2028. Increasing research & development (R & R&D) activities and the growing prevalence of infectious diseases are fueling the market’s growth. However, the potential risk of...

  • Infectious Disease
  • Vaccine
  • World
  • APAC
  • Middle East
  • Health Expenditure
  • Mortality Rate